You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

small volume accelerated chemoradiotherapy

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC (NSCLC) Trial in Worldwide (nivolumab, ipilimumab, durvalumab)

Active, not recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • nivolumab
  • +2 more
  • La Jolla, California
  • +182 more
Feb 1, 2023

Carcinoma, Small Cell Lung Trial in China (Atezolizumab, Tiragolumab, Placebo)

Active, not recruiting
  • Carcinoma, Small Cell Lung
  • Beijing City, China
  • +20 more
Dec 15, 2022

Advanced NSCLC Trial in China (KN046 (Recombinant Humanized PD-L1/CTLA-4 Bispecific Single Domain Antibody Fc Fusion Protein

Enrolling by invitation
  • Advanced Non-small Cell Lung Cancer
  • KN046 (Recombinant Humanized PD-L1/CTLA-4 Bispecific Single Domain Antibody Fc Fusion Protein Injection)
  • Axitinib
  • Hefei, Anhui, China
  • +5 more
Oct 26, 2022

NSCLC Trial in Worldwide (RO7247669, Pembrolizumab, Paclitaxel)

Recruiting
  • Non-small Cell Lung Cancer
  • Benowa, Queensland, Australia
  • +6 more
Mar 16, 2023

Locally Advanced NSCLC Trial in Edinburgh, London, Oxford (Atovaquone Oral Suspension, Standard of care chemo, Standard of care

Recruiting
  • Locally Advanced Non-Small Cell Lung Cancer
  • Atovaquone Oral Suspension
  • +2 more
  • Edinburgh, United Kingdom
  • +1 more
Dec 21, 2021

Locally Advanced NSCLC, Efficacy and Safety Trial in Guangzhou (Anlotinib, Chemotherapy, Radiotherapy)

Recruiting
  • Locally Advanced Non-small Cell Lung Cancer
  • Efficacy and Safety
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Jul 28, 2022

Lung Cancer Trial in Germany, Serbia, Switzerland (drug, radiation, procedure)

Active, not recruiting
  • Lung Cancer
  • Löwenstein, Germany
  • +24 more
Jan 9, 2023

Locally Advanced Lung Carcinoma Trial in Guangzhou (Concurrent chemo and single radiation dose climbing)

Recruiting
  • Locally Advanced Lung Carcinoma
  • Concurrent chemotherapy and single radiation dose climbing
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Jul 11, 2021

NSCLC Stage III Trial in Shanghai (standar thoracic RT dose, decreased thoracic RT dose)

Recruiting
  • Non-small Cell Lung Cancer Stage III
  • standar thoracic RT dose
  • decreased thoracic RT dose
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai jiaotong univestigy school of medicine
Sep 27, 2022

Nasopharyngeal Carcinoma, Induction Chemo, Radiotherapy Trial in Foshan, Zhongshan (Delineating the GTV according to the

Recruiting
  • Nasopharyngeal Carcinoma
  • +2 more
  • Delineating the GTV according to the pretreatment or post-IC tumor extension
  • Foshan, China
  • +1 more
Mar 18, 2022

Post-stroke Depression Trial in Ankara (The Magstim Rapid2 Plus Magnetic Stimulator (Magstim, Whitland, Dyfed, UK))

Completed
  • Post-stroke Depression
  • The Magstim Rapid2 Plus Magnetic Stimulator (Magstim, Whitland, Dyfed, UK)
  • Ankara, Turkey
    Ankara Bilkent City Hospital
Dec 3, 2023

Stage III NSCLC Trial in Birmingham (Adaptive Radiotherapy, Non-Adaptive Radiotherapy, Chemotherapy)

Not yet recruiting
  • Stage III Non-small Cell Lung Cancer
  • Adaptive Radiotherapy
  • +3 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Aug 3, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Obinutuzumab, Rituximab)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Dec 5, 2022

NSCLC, NSCLC Stage III, Recurrent Non Small Cell Lung Cancer Trial (Garmin Vivofit Activity Tracker)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • Garmin Vivofit Activity Tracker
  • (no location specified)
Aug 31, 2022

Small Cell Lung Cancer Trial in Guangzhou (q.d. RT, b.i.d.RT, etoposide and cisplatin)

Unknown status
  • Small Cell Lung Cancer
  • q.d. RT
  • +2 more
  • Guangzhou, Guangdong, China
    Sun yat-sen university cancer center
Jan 25, 2021

DETECT: Target Volume for Rectal Endoluminal Radiation Boosting

Recruiting
  • Rectal Cancer
  • Ultrasound
  • +2 more
  • Maastricht, Limburg, Netherlands
  • +2 more
Aug 24, 2022

MDD, MDD, Recurrent Episode, Severe, MDD, Recurrent, Moderate Trial in Minnetonka (NeuroStar TMS)

Completed
  • Major Depressive Disorder
  • +2 more
  • NeuroStar TMS
  • Minnetonka, Minnesota
    Sonder Behavioral Health and Wellness
Nov 3, 2023

Head Neck Cancer Trial in Billerica, Darmstadt (Xevinapant, Cisplatin, intensity-modulated radiation therapy (IMRT))

Not yet recruiting
  • Head and Neck Cancer
  • Billerica, Massachusetts
  • +1 more
Sep 20, 2023

Urinary Bladder Tumors Trial in Worldwide (Pembrolizumab, Conventional Radiotherapy (Bladder only), Conventional Radiotherapy

Recruiting
  • Urinary Bladder Neoplasms
  • Washington, District of Columbia
  • +120 more
Jan 19, 2023

NSCLC Stage III Trial in Hefei (Envafolimab)

Not yet recruiting
  • Non-small Cell Lung Cancer Stage III
  • Hefei, Anhui, China
    Anhui Provincial Cancer Hospital
Jun 8, 2022

Solid Tumor, Adult Trial in China (GT201)

Recruiting
  • Solid Tumor, Adult
  • Beijing, Beijing, China
  • +3 more
Nov 17, 2023

NSCLC, Stage III Trial in Chengdu (GFH018, Toripalimab, Paclitaxel)

Not yet recruiting
  • NSCLC, Stage III
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
May 23, 2022

Keratoconus Trial in Assiut (Accelerated crosslinking (ACXL))

Recruiting
  • Keratoconus
  • Accelerated crosslinking (ACXL)
  • Assiut, Egypt
    Tiba eye center
Jan 20, 2023

Mild Cognitive Impairment, Depression Trial in Charleston (Accelerated iTBS, Sham Comparator)

Not yet recruiting
  • Mild Cognitive Impairment
  • Depression
  • Accelerated iTBS
  • Sham Comparator
  • Charleston, South Carolina
    Medical University of South Carolina
Aug 7, 2023

Esophageal Squamous Cell Carcinoma, Chemoradiotherapy, Immunonutrition Trial in Hefei (Whole-course Immunonutrition Combined

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • +3 more
  • Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs
  • Hefei, China
    Anhui provincial hospital
Apr 16, 2023